Reports Search Total = 10

Middle East and Africa Flat Glass Market – Growth, Trends and Forecast (2019 – 2024)

Packaging Published by: Mordor Intelligence Market: Middle East & Africa
100 pages Published: 23-07-2019
  • Packaging
  • Mordor Intelligence
  • Middle East & Africa
  • 100 pages
  • Published: 23-07-2019

Market Overview

 

The Middle East & African Flat Glass Market was 6.390 billion in 2018 and is expected to be 9.6 billion by 2024 to register a CAGR of 6.91% over the forecast period of 2019-2024. With more than 10,000 construction projects currently active in the GCC, the demand for glass and glass-related products is booming, making Dubai the regional hub for global manufacturers to meet and do business, as indicated by experts at a key industry event in Dubai.

Flat glass finds two major modes of application in the automotive industry – original equipment (OE) supplied to manufacturers for new vehicles and automotive glass replacement (AGR) products supplied to the aftermarket for retrofit purposes, usually damages.

Sand, soda ash, limestone, and dolomite are the materials needed for the production of flat glass. Limestone is added to increase the durability of the product, whereas, dolomite is used to enhance the functional properties.

Dynamic shifts in the product standards, such as lightweight and non-fragile nature, are encouraging the flat glass manufacturers to incorporate the latest technological innovative methods. For instance, Abu Dhabi-based Al Heya Special Glass Factory launched its first ‘Made in UAE’ blast and bullet resistance glass, which can sustain the impact from a 0.40 caliber round, fired from a range of 10 m. The glass is also explosion resistant, and the firm’s production capacity will be around 240,000 m2 per year, for flat and curved glass

 

Scope of the Report

 

Plate glass, flat glass or sheet glass is a type of glass, initially produced in plane form, commonly used for windows, glass doors, transparent walls, and windscreens. For modern architectural and automotive applications, the flat glass is sometimes bent after production of the plane sheet.

 

Key Market Trends

 

Construction End-User Vertical to Account for the Largest Share

 

Construction is the largest end-user segment of the market studied. Similar to most of the oil-based economies around the globe, most of the Middle East & African economies were severely hit by the low crude oil price situation, during the past four years.

As a result, several residential and commercial construction works have been restrained, leading to a high number of backlogs, in recent years. The situation worsened further when the Organization of the Petroleum Exporting Countries (OPEC) decided to initiate production cuts, which influenced the demand for flat glass equipment, such as protective glass, which are in high demand, from the construction vehicles involved in the operations.

Additionally, the demand for flat glass, especially the insulated variants which are of high demand in the commercial construction sector, witnessed a decline, over the past few years. This can be attributed to the slowdown of the domestic construction sector. Even countries, like Saudi Arabia and UAE, faced all-time low occupancy rates, in office buildings and commercial places.

Moreover, the increasing investments of Asian vendors in the African market and a steady increase in the number of smart city initiatives in the region are expected to steadily increase the demand for flat glass, in the Middle East & African construction sector.

 

United Arab Emirates Accounts for a Major Share

 

The country remains a leading construction market in the GCC, and is on the track to deliver growth in 2018, in the lead up to Expo 2020, with steadily improving demand for the region’s building sector. The country also increased its expenditure on infrastructure and construction projects by about 43%, in 2018, as it continues to prepare for Expo 2020. The Dubai government has set aside a budget of AED 11.886 billion (USD 3.2 billion), for infrastructure projects. An estimated AED 5 billion has been allocated for Expo 2020 alone.

Governments across the Middle East are rolling out robust initiatives, to diversify their economies and shift from their reliance on oil to renewable energies, especially solar energy. These initiatives are also expected to bolster the growth of the market studied, over the forecast period.

According to the new regulations enforced by the Emirate’s Municipality and Planning Department, effective from June 2018, residences in Ajman city require a green permit, ahead of their construction.

In July 2018, Dubai Electricity and Water Authority (DEWA), in collaboration with the Emirates Green Building Council (EmiratesGBC), organized the Solar Decathlon Middle East Seminar, as the country aims to provide about 75% of its total power output from clean energy, by 2050.

 

Competitive Landscape

 

Major players, such as Asahi Glass, Saint Gobain, and Schott AG, are well known for their brand names and aggressive branding strategies. The robust dealer network established by the major players increases their competitiveness and dominance in the global as well as regional market.

Major vendors assert dominance in the study market by acquiring small players to venture into the market in the first place and extend their geographical reach and generate revenues through a powerful competitive strategy. Hence, the internal competition in the industry is very high, however, the evolving nature of the market and its reliance on technology innovation will create opportunities for local vendors to penetrate and intensify competition in the market.

Some of the key vendors in the Middle East and Africa Flat Glass Market are Saint-Gobain, ACG. Some of the key developments in the Middle East and Africa Flat Glass Market are as follows:

AGC has decided to raise the sales price of architectural glass-related products in Japan. The revised prices were to be in action from April 2018 or later. The scheduled price indicates an increase in the price of architectural glass, by at least 10%.

Saint-Gobain has announced to acquire 50% stake in a flat glass production line of the Chinese group JJG, located in Zibo in the Shandong province, Northeast China, with a total annual capacity of 160,000 metric ton. This acquisition may allow Saint-Gobain to almost double its production of basic glass in China, reinforcing the reliability of the flat glass supply for its Sekurit automotive glass factories. 

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Introduction to Market Drivers and Restraints

4.3 Market Drivers

4.4 Market Restraints

4.5 Value Chain Analysis

4.6 Industry Attractiveness Porters Five Force Analysis

4.6.1 Threat of New Entrants

4.6.2 Bargaining Power of Buyers/Consumers

4.6.3 Bargaining Power of Suppliers

4.6.4 Threat of Substitute Products

4.6.5 Intensity of Competitive Rivalry 

5 MARKET SEGMENTATION

5.1 By Product Type

5.1.1 Insulated Glass

5.1.2 Tempered Glass

5.1.3 Laminated Glass

5.1.4 Other Product Types

5.2 By End -User Vertical

5.2.1 Construction

5.2.2 Automotive

5.2.3 Other End-user Verticals

5.3 Geography

5.3.1 United Arab Emirates

5.3.2 Saudi Arabia

5.3.3 Egypt

5.3.4 Nigeria

5.3.5 South Africa

5.3.6 Rest Of Middle East & Africa

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 AGC Middle East & Africa FZCO

6.1.2 Saint-gobain Middle East Holding S.A.L

6.1.3 Schott AG

6.1.4 Corning Incorporated

6.1.5 PPG Industries LLC (VITRO SAB De CV)

6.1.6 Phoenicia Flat Glass Industries LTD

6.1.7 Guardian Glass LLC (Koch Industries)

6.1.8 Nippon Sheet Glass Co. Ltd

6.1.9 Kaveh Glass Group

6.1.10 Ghazvin Glass Co.

7 INVESTMENT OPPORTUNITIES

8 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

By Product Type

Insulated Glass

Tempered Glass

Laminated Glass

Other Product Types

 

By End -User Vertical

Construction

Automotive

Other End-user Verticals

 

Geography

United Arab Emirates

Saudi Arabia

Egypt

Nigeria

South Africa

Rest Of Middle East & Africa

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Middle East & Africa Human Insulin Market – Growth, Trends and Forecast (2019 – 2024)

Healthcare Published by: Mordor Intelligence Market: Middle East & Africa
100 pages Published: 23-07-2019
  • Healthcare
  • Mordor Intelligence
  • Middle East & Africa
  • 100 pages
  • Published: 23-07-2019

Market Overview

 

– The Middle East & Africa human insulin market has potential to grow, and it is expected to grow at approximately 4% CAGR during the forecast period (2019-2024).

– Nearly 100 million people around the world need insulin, including all the people living with Type 1 Diabetes, and between 10-25% of people with Type 2 Diabetes.

– Although insulin has been used in the treatment of diabetes for over 90 years, globally, more than half of those who need insulin today still cannot afford it and cannot access it.

– People with Type 1 Diabetes need Insulin therapy, and the treatment focuses on managing blood sugar levels with insulin, diet, and lifestyle habits to prevent complications.

 

Scope of the Report

 

The Middle East & Africa human insulin market is segmented by Product Type (Basal or Long-acting Insulins, Bolus or Fast-acting Insulins, Traditional Human Insulins, Combination Insulins, and Biosimilar Insulins), and by Region, which covers Saudi Arabia, Iran, Egypt, South Africa, Oman & the Rest of Middle East & Africa.

 

Key Market Trends

 

Increasing Diabetes Prevalence is Expected to Boost the Market in the Forecast Period

 

– The prevalence of Type 2 Diabetes mellitus (T2DM) has increased dramatically during the last two decades – a fact driven by the increased prevalence of obesity, the primary risk factor for T2DM. Many reports and surveys documented a drastic increase in the diabetic population based on lifestyle habits. High growth in urbanization has worsened physical inactivity, and in turn, making diabetes is a major health concern.

– The R&D in the insulin segments are growing year-on-year, where scientists are trying to bring out the best molecule for patients use by curbing the maximum extent of side effects, and by increasing their efficiency.

 

Biosimilar Insulins hold a Significant Market Share

 

– Biosimilar insulin is highly popular in the Middle East & Africa region because of its low cost as compared to branded insulins.

– The Middle Eastern & African countries have substantial economic diversity. The per-capita expenditure on diabetes in the region is low, although some countries in the region have managed to modify their healthcare expenditure to include biologic and biosimilar therapies.

– Biosimilars have grown with a high CAGR of 13% in the historical period because of consistent efforts by local manufacturers to capture the highly consolidated market.

 

Competitive Landscape

 

– The Middle East & Africa insulin market is dominated by Novo Nordisk, Sanofi and Eli Lilly. However, there are many local players like Julphar, Sedico, and Exir, who hold a significant market share.

– Julphar is developing Insulin Glargine Biosimilar, which is expected to launch in 2020.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Drivers

4.3 Restraints

4.4 Porter’s Five Forces Analysis

4.4.1 Bargaining Power of Suppliers

4.4.2 Bargaining Power of Consumers

4.4.3 Threat of New Entrants

4.4.4 Threat of Substitute Products and Services

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Drug

5.1.1 Insulin (Value and Volume, 2012-2024)

5.1.1.1 Basal or Long-acting Insulins

5.1.1.1.1 Lantus (Insulin Glargine)

5.1.1.1.2 Levemir (Insulin Detemir)

5.1.1.1.3 Toujeo (Insulin Glargine)

5.1.1.1.4 Tresiba (Insulin Degludec)

5.1.1.1.5 Basaglar (Insulin Glargine)

5.1.1.2 Bolus or Fast-acting Insulins

5.1.1.2.1 NovoRapid/Novolog (Insulin Aspart)

5.1.1.2.2 Humalog (Insulin Lispro)

5.1.1.2.3 Apidra (Insulin Glulisine)

5.1.1.3 Traditional Human Insulins

5.1.1.3.1 Novolin/Actrapid/Insulatard

5.1.1.3.2 Humilin

5.1.1.3.3 Insuman

5.1.1.4 Biosimilar Insulins

5.1.1.4.1 Insulin Glargine Biosimilars

5.1.1.4.2 Human Insulin Biosimilars

5.1.1.5 Insulin Combinations

5.1.1.5.1 NovoMix (Biphasic Insulin Aspart)

5.1.1.5.2 Ryzodeg (Insulin Degludec and Insulin Aspart)

5.1.1.5.3 Xultophy (Insulin Degludec and Liraglutide)

5.2 Geography

5.2.1 Middle East & Africa (Value and Volume, 2012-2024)

5.2.1.1 Saudi Arabia

5.2.1.1.1 Basal or Long-acting Insulins

5.2.1.1.2 Bolus or Fast-acting Insulins

5.2.1.1.3 Traditional Human Insulins

5.2.1.1.4 Biosimilar Insulins

5.2.1.1.5 Insulin Combinations

5.2.1.2 Iran

5.2.1.2.1 Basal or Long-acting Insulins

5.2.1.2.2 Bolus or Fast-acting Insulins

5.2.1.2.3 Traditional Human Insulins

5.2.1.2.4 Biosimilar Insulins

5.2.1.2.5 Insulin Combinations

5.2.1.3 Egypt

5.2.1.3.1 Basal or Long-acting Insulins

5.2.1.3.2 Bolus or Fast-acting Insulins

5.2.1.3.3 Traditional Human Insulins

5.2.1.3.4 Biosimilar Insulins

5.2.1.3.5 Insulin Combinations

5.2.1.4 Oman

5.2.1.4.1 Basal or Long-acting Insulins

5.2.1.4.2 Bolus or Fast-acting Insulins

5.2.1.4.3 Traditional Human Insulins

5.2.1.4.4 Biosimilar Insulins

5.2.1.4.5 Insulin Combinations

5.2.1.5 South Africa

5.2.1.5.1 Basal or Long-acting Insulins

5.2.1.5.2 Bolus or Fast-acting Insulins

5.2.1.5.3 Traditional Human Insulins

5.2.1.5.4 Biosimilar Insulins

5.2.1.5.5 Insulin Combinations

5.2.1.6 Rest of Middle and Africa

5.2.1.6.1 Basal or Long-acting Insulins

5.2.1.6.2 Bolus or Fast-acting Insulins

5.2.1.6.3 Traditional Human Insulins

5.2.1.6.4 Biosimilar Insulins

5.2.1.6.5 Insulin Combinations

6 MARKET INDICATORS

6.1 Type-1 Diabetes Population (2012-2024)

6.2 Type-2 Diabetes Population (2012-2024)

7 COMPETITIVE LANDSCAPE

7.1 Company Profiles

7.1.1 Novo Nordisk

7.1.2 Eli Lilly

7.1.3 Sanofi

7.1.4 Boehringer Ingelheim

7.1.5 Julphar

7.1.6 Exir

7.1.7 Sedico

8 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

By Drug

Insulin (Value and Volume, 2012-2024)

Basal or Long-acting Insulins

Lantus (Insulin Glargine)

Levemir (Insulin Detemir)

Toujeo (Insulin Glargine)

Tresiba (Insulin Degludec)

Basaglar (Insulin Glargine)

Bolus or Fast-acting Insulins

NovoRapid/Novolog (Insulin Aspart)

Humalog (Insulin Lispro)

Apidra (Insulin Glulisine)

Traditional Human Insulins

Novolin/Actrapid/Insulatard

Humilin

Insuman

Biosimilar Insulins

Insulin Glargine Biosimilars

Human Insulin Biosimilars

Insulin Combinations

NovoMix (Biphasic Insulin Aspart)

Ryzodeg (Insulin Degludec and Insulin Aspart)

Xultophy (Insulin Degludec and Liraglutide)

 

Geography

Middle East & Africa (Value and Volume, 2012-2024)

Saudi Arabia

Basal or Long-acting Insulins

Bolus or Fast-acting Insulins

Traditional Human Insulins

Biosimilar Insulins

Insulin Combinations

Iran

Basal or Long-acting Insulins

Bolus or Fast-acting Insulins

Traditional Human Insulins

Biosimilar Insulins

Insulin Combinations

Egypt

Basal or Long-acting Insulins

Bolus or Fast-acting Insulins

Traditional Human Insulins

Biosimilar Insulins

Insulin Combinations

Oman

Basal or Long-acting Insulins

Bolus or Fast-acting Insulins

Traditional Human Insulins

Biosimilar Insulins

Insulin Combinations

South Africa

Basal or Long-acting Insulins

Bolus or Fast-acting Insulins

Traditional Human Insulins

Biosimilar Insulins

Insulin Combinations

Rest of Middle and Africa

Basal or Long-acting Insulins

Bolus or Fast-acting Insulins

Traditional Human Insulins

Biosimilar Insulins

Insulin Combinations

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Middle East & Africa E-Cigarettes Market- Growth, Trends, and Forecast (2019 – 2024)

Consumer Goods and Services Published by: Mordor Intelligence Market: Middle East & Africa
91 pages Published: 23-07-2019
  • Consumer Goods and Services
  • Mordor Intelligence
  • Middle East & Africa
  • 91 pages
  • Published: 23-07-2019

Market Overview

 

The Middle East & African e-cigarettes market was valued at USD 267.9 million in 2018 and is estimated to register CAGR of 9.74%, during the forecast period. Over the past few years, there has been a rising awareness regarding the health hazards associated with smoking. This has resulted in high demand for alternatives to traditional cigarettes, like e-cigarettes. E-cigarettes were introduced as an alternative to traditional cigarettes. According to the estimates provided by the World Bank, 180 million premature deaths can be avoided if smoking cigarettes can be reduced to one-half by 2025, and e-cigarettes are a major step toward this achievement. With the growing popularity of vaping devices, flavor and fragrance vendors are introducing a wide variety of e-liquids to attract consumers. Different flavors, such as menthol, mint, chocolate, cola, bubble gum, and fusions of other fruits and flavoring substances, are luring a large number of consumers to adopt these e-cigarette devices. Tobacco manufacturers are focusing on technological developments and innovation, in order to attain an edge over the competitors. This has persuaded vendors to heavily invest in technology

 

Scope of the Report

 

E-cigarettes are also called vaping devices. They could contain e-liquids and can also include a miscellaneous group of devices that allow users to inhale an aerosol, which contains nicotine, flavorings, and other spices. Various types of flavors, such as mint, menthol, chocolate, cola, bubble gum, fusions of other fruits and flavoring ingredients are attracting a large number of consumers to adopt them.

 

Key Market Trends

 

Penetration of E-cigarettes in Organized Retail

 

The evolving retail industry, especially in developing countries, is marked by the emergence of many stores in the hypermarket, supermarket, and specialty store formats. The penetration of organized retail is also expected to enable consumers to seek information about various brands and compare prices and quality, which results in a better purchase decision. Vendors leverage both traditional and social media platforms for advertising. Companies create campaigns and exhibition shows to promote their brands and products, reaching out to their target audience through various social media platforms. Now, with the increasing demand, several companies have invested heavily in finding new distribution channels. Thus, e-cigarettes are available for users across a range of channels. With the growth of e-commerce and many retail stores planning to introduce e-cigarettes in their line-up to match the competition, e-cigarettes are becoming relatively easy to procure. This is driving the faster adoption of the product, resulting in healthy market growth.

 

Egypt Dominates the Market

 

Vaping is a modern trend, but even new vapes have their roots in ancient history. Egypt is known for its ancient vaping techniques, such as heating herbs and oils on hot stones to vape. According to ‘The Egyptian Journal of Hospital Medicine’, in 2016, a study was conducted in Egypt, and the results of the study showed that 57.5% of the respondents were aware of e-cigarettes. Among those who know about e-cigarettes, 41.6% believed that e-cigarettes help smoking cessation and 31.9% believed that it is less harmful than traditional cigarettes. Vendors operating in the country are introducing innovative products, in terms of functionality, flavors, ingredients, packaging, and format. Rising consumer awareness and product knowledge about various e-cigarettes have led to the introduction of high-performance and quality products in the Egyptian e-cigarettes market. The electronic cigarette and e-liquid from Intellicig Egypt have revolutionized the smoking experience for the smokers. Intellicig is one of the largest electronic cigarette manufacturer in the Egyptian market and the only company that offers its clients, after-sale service and care.

 

Competitive Landscape

 

British American Tobacco Plc. held the largest market share of the overall e-cigarette market in 2017 and strengthened its position with the acquisition of Reynolds American Inc. However, the Competition Commission blocked British American Tobacco (BAT) SA’s plans to expand into e-cigarettes in SA, with the acquisition of the Twisp, a vaping company, and has prevented the deal on the grounds that it would substantially lessen competition, impacting the company’s position. The company is subject to significantly increased competition, with Phillip Morris International, joining the vaping trend and encouraging smokers to switch to new generation devices that were claimed to be healthier in some regions. Over the past decade, Marlboro, one of the leading cigarette brands,  invested USD 4.5 billion in R&D, in order to develop advanced technology. The firm has also filed patents, with more than 3,400 granted and over 5,000 pending.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.3 Market Restraints

4.4 Porter Five Forces Analysis

4.4.1 Bargaining Power of Suppliers

4.4.2 Bargaining Power of Buyers

4.4.3 Threat of New Entrants

4.4.4 Threat of Substitute Products and Services

4.4.5 Degree of Competition

5 MARKET SEGMENTATION

5.1 Product

5.1.1 E-cigarette Devices

5.1.2 E-liquid Devices

5.2 Distribution Channel

5.2.1 Offline Channel

5.2.2 Online Channel

5.3 Geography

5.3.1 South Africa

5.3.2 Nigeria

5.3.3 Kenya

5.3.4 Ghana

5.3.5 Egypt

5.3.6 Rest of Middle East & Africa

6 Competitive Landscape

6.1 Most Adopted Strategies

6.2 Market Share Analysis

6.3 Company Profiles

6.3.1 British American Tobacco

6.3.2 Joyetech Group

6.3.3 VIP Electronic Cigarettes

6.3.4 Philip Morris International Inc.

6.3.5 Aspire

6.3.6 KangerTech

6.3.7 RITCHY GROUP

6.3.8 Innokin Technology

6.3.9 Ecigs Solutions Ltd

6.3.10 Intellicig Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

Product

E-cigarette Devices

E-liquid Devices

 

Distribution Channel

Offline Channel

Online Channel

 

Geography

South Africa

Nigeria

Kenya

Ghana

Egypt

Rest of Middle East & Africa

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Middle East & Africa Diabetes Drugs Market – Growth, Trends, and Forecast (2019 – 2024)

Healthcare Published by: Mordor Intelligence Market: Middle East & Africa
70 pages Published: 22-07-2019
  • Healthcare
  • Mordor Intelligence
  • Middle East & Africa
  • 70 pages
  • Published: 22-07-2019

Market Overview

 

– The Middle East & Africa diabetes drugs market (henceforth, referred to as the market studied) was valued at USD 2793.99 million in 2018, and it is expected to witness a CAGR of 6.48% during the forecast period 2019 – 2024, primarily due to the growing geriatric population.

– In most countries in the Middle East region, it is estimated that approximately USD 17 billion are spent on diabetes by consumers.

– The major cause for the growing diabetic population in this region is unhealthy lifestyles and urbanization.

– Most of the countries in the region has seen tremendous economic and industrial development in recent times, resulting in a shift in social behaviors.

 

Scope of the Report

 

The Middle East & Africa diabetes drugs market is segmented by product type (oral anti-diabetic drugs, insulin, non-insulin injectable drugs, and combination drugs) and geography.

 

Key Market Trends

 

Around 16 million People are Suffering from Diabetes in the Middle East & Africa Region

 

– In Middle East & Africa (MEA), 15.51 million people are suffering from diabetes, and this population is expected to increase in the forecast period with a CAGR of 4.46%.

– In the MEA region, in 2018, the obesity rate was high with 42 million people, which was 21% of the total population. Obesity may lead to type-2 diabetes in the future.

– Egypt and Saudi Arabia have the highest diabetic population, with 53.3% and 28.2% market share in the market studied, respectively.

– For most of the population, sedentary lifestyles and endless fast-food options have replaced the traditional ways of work, travel, and cuisine, increasing the chance of getting diseases, such as type-2 diabetes.

– Increasing population and rising per capita income in these countries may result in increasing healthcare expenditure, which may drive the market studied during the forecast period (2019-2024).

 

Saudi Arabia Holds the Highest Market Share

 

– Saudi Arabia accounts for the largest market share in the MEA diabetic drugs market, which is close to 25.35% in 2018, and Oman is expected to witness the highest growth rate of 10.45% during the forecast period (2019-2024).

– The increasing sales of diabetic drugs in Saudi Arabia are due to the growing prevalence of diabetes in the country.

– The Middle Eastern countries have high diabetes prevalence, like Saudi Arabia – 24%, Kuwait – 23%, Bahrain – 22%, Qatar – 20%, and UAE – 19%.

– In 2018, insulin accounted for close to 33.37% of market share in the market studied. The insulin segment of the market studied in the MENA region was valued at 932.27 million in 2018, and it is expected to register a CAGR of 4.12% during the forecast period (2019-2024), where Saudi Arabia is expected to occupy 32.33% of the market share.

 

Competitive Landscape

 

There have been constant innovations driven by manufacturers to compete and struggle in the market studied.

 

– Glynase and Diatab, which are considered to be generic medication, had high sales in the Middle East region, but were deemed to fall below the standards of the treatment, on which they were based. Thus, with the notification of the Saudi Food and Drug Authority (SFDA), the decision of withdrawing these drugs was announced by the National Health Regulatory Authority (NHRA). 

– A new study on SGLT2 Class (Jardiance, Farxiga) reflects that the drug helps in treating kidney and cardio vascular diseases.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Drivers

4.3 Restraints

4.4 Porter’s Five Forces Analysis

4.4.1 Bargaining Power of Suppliers

4.4.2 Bargaining Power of Consumers

4.4.3 Threat of New Entrants

4.4.4 Threat of Substitute Products and Services

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Product Type

5.1.1 Oral Anti-diabetic Drugs

5.1.1.1 Biguanide (Value and Volume 2012-2024)

5.1.1.1.1 Metformin

5.1.1.2 Alpha – Glucosidase Inhibitors (Value and Volume 2012-2024)

5.1.1.2.1 Alpha – Glucosidase Inhibitors

5.1.1.3 Sodium – glucose Cotransport -2 (SGLT-2) Inhibitor (Value and Volume 2012-2024)

5.1.1.3.1 Invokana (Canagliflozin)

5.1.1.3.2 Jardiance (Empagliflozin)

5.1.1.3.3 Farxiga/Forxiga (Dapagliflozin)

5.1.1.3.4 Suglat (Ipragliflozin)

5.1.1.4 Dipeptidyl Peptidase – 4 (DPP-4) Inhibitors (Value and Volume 2012-2024)

5.1.1.4.1 Januvia (Sitagliptin)

5.1.1.4.2 Onglyza (Saxagliptin)

5.1.1.4.3 Tradjenta (Linagliptin)

5.1.1.4.4 Vipidia/Nesina (Alogliptin)

5.1.1.4.5 Galvus (Vildagliptin)

5.1.1.5 Sulfonylureas (Value and Volume 2012-2024)

5.1.1.5.1 Sulfonylureas

5.1.1.6 Meglitinide (Value and Volume 2012-2024)

5.1.1.6.1 Meglitinide

5.1.2 Insulin

5.1.2.1 Basal or Long Acting Insulins

5.1.2.1.1 Lantus (Insulin Glargine)

5.1.2.1.2 Levemir (Insulin Detemir)

5.1.2.1.3 Toujeo (Insulin Glargine)

5.1.2.1.4 Tresiba (Insulin Degludec)

5.1.2.1.5 Basaglar (Insulin Glargine)

5.1.2.2 Bolus or Fast Acting Insulins

5.1.2.2.1 NovoRapid/Novolog (Insulin Aspart)

5.1.2.2.2 Humalog (Insulin Lispro)

5.1.2.2.3 Apidra (Insulin Glulisine)

5.1.2.3 Traditional Human Insulins

5.1.2.3.1 Novolin/Actrapid/Insulatard

5.1.2.3.2 Humilin

5.1.2.3.3 Insuman

5.1.2.4 Biosimilar Insulins

5.1.2.4.1 Insulin Glargine Biosimilars

5.1.2.4.2 Human Insulin Biosimilars

5.1.3 Non-Insulin Injectable Drugs

5.1.3.1 GLP1 Receptor Agonists

5.1.3.1.1 Victoza (Liraglutide)

5.1.3.1.2 Byetta (Exenatide)

5.1.3.1.3 Bydureon (Exenatide)

5.1.3.1.4 Trulicity (Dulaglutide)

5.1.3.1.5 Lyxumia (Lixisenatide)

5.1.4 Combination Drugs

5.1.4.1 Insulin Combinations

5.1.4.1.1 NovoMix (Biphasic Insulin Aspart)

5.1.4.1.2 Ryzodeg (Insulin Degludec and Insulin Aspart)

5.1.4.1.3 Xultophy (Insulin Degludec and Liraglutide)

5.1.4.2 Oral Combination

5.1.4.2.1 Janumet (Sitagliptin and Metformin HCl)

5.2 Geography

5.2.1 Middle East & Africa (Value and Volume, 2012-2024)

5.2.1.1 Saudi Arabia

5.2.1.1.1 Oral Anti-diabetic Drugs

5.2.1.1.2 Insulin

5.2.1.1.3 Non-Insulin Injectable Drugs

5.2.1.1.4 Combination Drugs

5.2.1.1.5 By Company (Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Astellas, Janssen, Merck, and Other Companies

5.2.1.2 Iran

5.2.1.2.1 Oral Anti-diabetic Drugs

5.2.1.2.2 Insulin

5.2.1.2.3 Non-Insulin Injectable Drugs

5.2.1.2.4 Combination Drugs

5.2.1.2.5 By Company (Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Astellas, Janssen, Merck, and Other Companies

5.2.1.3 Egypt

5.2.1.3.1 Oral Anti-diabetic Drugs

5.2.1.3.2 Insulin

5.2.1.3.3 Non-Insulin Injectable Drugs

5.2.1.3.4 Combination Drugs

5.2.1.3.5 By Company (Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Astellas, Janssen, Merck, and Other Companies

5.2.1.4 Oman

5.2.1.4.1 Oral Anti-diabetic Drugs

5.2.1.4.2 Insulin

5.2.1.4.3 Non-Insulin Injectable Drugs

5.2.1.4.4 Combination Drugs

5.2.1.4.5 By Company (Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Astellas, Janssen, Merck, and Other Companies

5.2.1.5 South Africa

5.2.1.5.1 Oral Anti-diabetic Drugs

5.2.1.5.2 Insulin

5.2.1.5.3 Non-Insulin Injectable Drugs

5.2.1.5.4 Combination Drugs

5.2.1.5.5 By Company (Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Astellas, Janssen, Merck, and Other Companies

5.2.1.6 Rest of Middle & Africa

5.2.1.6.1 Oral Anti-diabetic Drugs

5.2.1.6.2 Insulin

5.2.1.6.3 Non-Insulin Injectable Drugs

5.2.1.6.4 Combination Drugs

5.2.1.6.5 By Company (Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Astellas, Janssen, Merck, and Other Companies

6 MARKET INDICATORS

6.1 Type-1 Diabetic Population (2012-2024)

6.2 Type-2 Diabetic Population (2012-2024)

7 COMPETITIVE LANDSCAPE

7.1 Company Profiles

7.1.1 Takeda

7.1.2 Pfizer

7.1.3 Eli Lilly

7.1.4 Janssen Pharmaceuticals

7.1.5 Astellas

7.1.6 Boehringer Ingelheim

7.1.7 Merck And Co.

7.1.8 AstraZeneca

7.1.9 Bristol Myers Squibb

7.1.10 Novartis

7.1.11 Sanofi

8 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

By Product Type

Oral Anti-diabetic Drugs

Biguanide (Value and Volume 2012-2024)

Metformin

Alpha – Glucosidase Inhibitors (Value and Volume 2012-2024)

Alpha – Glucosidase Inhibitors

Sodium – glucose Cotransport -2 (SGLT-2) Inhibitor (Value and Volume 2012-2024)

Invokana (Canagliflozin)

Jardiance (Empagliflozin)

Farxiga/Forxiga (Dapagliflozin)

Suglat (Ipragliflozin)

Dipeptidyl Peptidase – 4 (DPP-4) Inhibitors (Value and Volume 2012-2024)

Januvia (Sitagliptin)

Onglyza (Saxagliptin)

Tradjenta (Linagliptin)

Vipidia/Nesina (Alogliptin)

Galvus (Vildagliptin)

Sulfonylureas (Value and Volume 2012-2024)

Sulfonylureas

Meglitinide (Value and Volume 2012-2024)

Meglitinide

Insulin

Basal or Long Acting Insulins

Lantus (Insulin Glargine)

Levemir (Insulin Detemir)

Toujeo (Insulin Glargine)

Tresiba (Insulin Degludec)

Basaglar (Insulin Glargine)

Bolus or Fast Acting Insulins

NovoRapid/Novolog (Insulin Aspart)

Humalog (Insulin Lispro)

Apidra (Insulin Glulisine)

Traditional Human Insulins

Novolin/Actrapid/Insulatard

Humilin

Insuman

Biosimilar Insulins

Insulin Glargine Biosimilars

Human Insulin Biosimilars

Non-Insulin Injectable Drugs

GLP1 Receptor Agonists

Victoza (Liraglutide)

Byetta (Exenatide)

Bydureon (Exenatide)

Trulicity (Dulaglutide)

Lyxumia (Lixisenatide)

Combination Drugs

Insulin Combinations

NovoMix (Biphasic Insulin Aspart)

Ryzodeg (Insulin Degludec and Insulin Aspart)

Xultophy (Insulin Degludec and Liraglutide)

Oral Combination

Janumet (Sitagliptin and Metformin HCl)

 

Geography

Middle East & Africa (Value and Volume, 2012-2024)

Saudi Arabia

Oral Anti-diabetic Drugs

Insulin

Non-Insulin Injectable Drugs

Combination Drugs

By Company (Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Astellas, Janssen, Merck, and Other Companies

Iran

Oral Anti-diabetic Drugs

Insulin

Non-Insulin Injectable Drugs

Combination Drugs

By Company (Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Astellas, Janssen, Merck, and Other Companies

Egypt

Oral Anti-diabetic Drugs

Insulin

Non-Insulin Injectable Drugs

Combination Drugs

By Company (Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Astellas, Janssen, Merck, and Other Companies

Oman

Oral Anti-diabetic Drugs

Insulin

Non-Insulin Injectable Drugs

Combination Drugs

By Company (Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Astellas, Janssen, Merck, and Other Companies

South Africa

Oral Anti-diabetic Drugs

Insulin

Non-Insulin Injectable Drugs

Combination Drugs

By Company (Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Astellas, Janssen, Merck, and Other Companies

Rest of Middle & Africa

Oral Anti-diabetic Drugs

Insulin

Non-Insulin Injectable Drugs

Combination Drugs

By Company (Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Astellas, Janssen, Merck, and Other Companies

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Middle East & Africa Ammunition Market – Growth, Trends, and Forecast (2019 – 2024)

Aerospace & Defense Published by: Mordor Intelligence Market: Middle East & Africa
91 pages Published: 22-07-2019
  • Aerospace & Defense
  • Mordor Intelligence
  • Middle East & Africa
  • 91 pages
  • Published: 22-07-2019

Market Overview

 

The Middle East & Africa ammunition market (henceforth, referred to as the market studied) is anticipated to register a CAGR of over 3.5%, during the forecast period.

 

    – In Africa, many illegal activities, like smuggling, illegal mining, poaching, etc. are taking place, and countries in the Middle East, such as Libya, Syria, and Yemen, have been fighting civil wars. Increasing terrorist activities and the growth of radicals in many countries in Middle East & Africa are forcing the governments to strengthen their law enforcement agencies and military. This may boost the procurement of ammunition in the coming years.

    – High military spending of many countries in the Middle East region is also a growth driver for the market studied in the region.

    – Countries in the Middle East are currently focusing on the development of their indigenous military manufacturing capabilities. This is expected to further strengthen the market in the region.

 

Scope of the Report

 

Ammunition includes all types of objects, which can be fired from a weapon that is either lethal or non-lethal. The military segment includes procurements by the military (army, navy, and air force), homeland security, local law enforcement agencies, border security forces, and special forces. The civilian segment includes the use of ammunition for sports and civilian uses. Furthermore, the market study includes the following aspects:

 

Key Market Trends

 

The Military Segment had the Highest Market Share in 2018

 

At present, the military segment has the highest market share compared to the civilian segment. The large difference in shares is primarily attributed to the large procurement quantities of ammunition for military and law enforcement purposes. The increasing terrorist, rebel, and illegal activities in the region are demanding a high involvement of army, navy, air force, and law enforcement agencies to tackle these issues. Growth in the military segment is also expected to be high, as the governments in the region are trying to strengthen their militaries. 

 

Saudi Arabia is Expected to Generate the Highest Demand for Ammunition During the Forecast Period

 

Saudi Arabia was the largest importer of arms in the world, during 2014 – 2018, accounted for 12% of the total arms imported during that period. Apart from the imports, the country also has local ammunition manufacturers, like SAMI that supplies ammunition to its military. Thus, the market in the country is the largest in the Middle East & Africa region. However, over the same period, the imports from Kuwait and Israel have grown by around 350%, while that of Egypt, Qatar, and Oman have a growth of about 200%. The markets in these countries are expected to grow further, owing to the ongoing procurements of new combat aircraft and armored vehicles, which may generate demand for the respective ammunitions used in those vehicles. 

 

Competitive Landscape

 

Previously, major Western arms manufacturers sold their ammunition mostly to NATO allies and other European states. However, now the focus is shifted to the Middle East & African region. More than one-third of the total arms imports in the world are from this region. Thus, the market is primarily dominated by foreign players. However, the growth of local manufacturers, like SAMI, Elbit Systems PLC, etc., has started in the past decade, and slowly their share is growing. In addition, Saudi Arabia, the world’s largest importer of arms, has decided to up the share of its local defense manufacturing by 50% by 2030. This move is expected to change the dynamics of the market studied during the forecast period.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.3 Market Restraints

4.4 PESTLE Analysis

5 MARKET SEGMENTATION

5.1 Type

5.1.1 Small Caliber

5.1.2 Medium Caliber

5.1.3 Large Caliber

5.1.4 Mortar and Artillery Ammunition

5.2 Application

5.2.1 Non-lethal

5.2.2 Lethal

5.3 End User

5.3.1 Civilian

5.3.2 Military

5.4 Country

5.4.1 Saudi Arabia

5.4.2 Egypt

5.4.3 UAE

5.4.4 Iraq

5.4.5 Israel

5.4.6 Rest of Middle East & Africa

6 COMPETITIVE LANDSCAPE

6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements

6.2 Vendor Market Share

6.3 Strategies Adopted by Leading Players

6.4 Company Profiles

6.4.1 BAE Systems PLC

6.4.2 Rheinmetall AG

6.4.3 Nexter Munitions

6.4.4 Lockheed Martin Corporation

6.4.5 General Dynamics Ordnance and Tactical Systems

6.4.6 Northrop Grumman Corporation

6.4.7 Denel PMP

6.4.8 SAMI

6.4.9 Emirates Defense Industries Company (BARIJ Munitions)

6.4.10 BMC

6.4.11 ASELSAN

6.4.12 Elbit Systems*

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

Type

Small Caliber

Medium Caliber

Large Caliber

Mortar and Artillery Ammunition

 

Application

Non-lethal

Lethal

 

End User

Civilian

Military

 

Country

Saudi Arabia

Egypt

UAE

Iraq

Israel

Rest of Middle East & Africa

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Africa Vegetable Seed Market – Growth, Trends, and Forecast (2019 – 2024)

Agriculture Published by: Mordor Intelligence Market: Middle East & Africa
108 pages Published: 28-06-2019
  • Agriculture
  • Mordor Intelligence
  • Middle East & Africa
  • 108 pages
  • Published: 28-06-2019

Market Overview

 

The Africa Vegetable Seed Market was valued at USD 190 million in 2018 and is projected to grow at a CAGR of 6.0% during the forecast period (2019-2024). South Africa is the largest region which is accounting for largest production of vegetable seeds.The drivers identified in this market are organizations promoting vegetable breeding,increasing demand for economic development and nutrition security and increasing demand for employment and income generation. The restraints identified in this market are low access to high-quality seeds of improved and adapted varieties,high capital investment and operational costs and lack of awareness of the nutritional benefits.

 

Scope of the Report

 

A seed is a mature ovule consisting of an embryonic plant (dormant) along with the stored nutrients required for the embryonic plant, all surrounded by a protective coat. A seed is a living entity and a biological product that can die, depending upon its genetic potential to remain viable and its storage conditions. Seeds can be classified in various ways, such as botanical characters (botanical classification), crop type, uses, etc.The report contains a detailed analysis on various parameters of the African vegetable seed market. The market has been segmented, based on region and vegetable type.

 

Key Market Trends

 

Increasing Demand for Economic Development and Nutrition Security is driving the market

 

A major threat alarming Africa is its nutritional insecurity and deficient diet plans. Vegetables are important sources of micronutrients and fibers. In Africa, government authorities are adopting a strict commitment toward the development of nutritional security. In low-income countries from Africa, meeting caloric requirements is a priority, and the inclusion of vegetables in diet plans serves as an alternative to meeting the caloric requirements. Scientists and different seed companies are investing heavily in R&D, to develop highly nutritious and yielding seed varieties. By utilizing these newly developing vegetable seed varieties, the expansion of home gardens is planned in several countries, with an aim to contribute to the growth of nutritional security in Africa. The agencies like The New Partnership for Africa’s Development (NEPAD) Agency, along with various international, local, and government associations, are supporting the Africa nutritional security programs.

 

Africa Vegetable Seed Market is segmented by Vegetables into Tomato

 

The tomato seed segment of the market studied was estimated to be worth USD 25.7 million in 2018 and is projected to reach USD 37.1 million by 2024, projecting to register a CAGR of 6.3% during the forecast period. Among fresh tomatoes, Florodade, Heinz 1370, Karino, and Rodade are the popular cultivars. Popular newer hybrids in the market include – Fortress, Hytec, Star 9001, Star 9003, Sundance, and Zeal. Algeria, Benin, Cameroon, Egypt, Ghana, Kenya, Sudan, Tunisia, and the United Republic of Tanzania are the major countries in the Rest of Africa segment. All these countries have more than 20,000 hectares of yearly tomato cultivation.

 

Competitive Landscape

 

In the African vegetable seed market, companies are not only competing based on product quality and promotion but are also focused on strategic moves, to hold a larger market share. The African vegetable seed market is fragmented, and no company has a clear stronghold in the market. This is largely due to the fact that the market is fragile and there is no regulation on seed quality and labeling, which allows the local companies to circulate their products easily in the market. Syngenta’s acquisition of MRI Zambia and its recent expansion activities provide it a strong presence in the African vegetable seed market.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.3 Market Restraints

4.4 Industry Attractiveness – Porter’s Five Force Analysis

4.4.1 Bargaining Power of Suppliers

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Threat of New Entrants

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry 

5 MARKET SEGMENTATION

5.1 Crop Type

5.1.1 Tomato

5.1.2 Cabbage

5.1.3 Onion

5.1.4 Carrot

5.1.5 Okra

5.1.6 Others

5.2 Geography

5.2.1 Africa

5.2.1.1 Kenya

5.2.1.2 Uganda

5.2.1.3 Nigeria

5.2.1.4 South Africa

5.2.1.5 Rest of Africa

6 COMPETITIVE LANDSCAPE

6.1 Most Adopted Competitor Strategies

6.2 Market Share Analysis

6.3 Company Profiles

6.3.1 Monsanto

6.3.2 Kenya Seed Company

6.3.3 East African Seeds Co.

6.3.4 Rijk Zwaan Africa

6.3.5 Hygrotech

6.3.6 Premier Seeds Nigeria Limited

6.3.7 Sakata Seed Southern Africa (Pty) Ltd

6.3.8 Syngenta

6.3.9 East-West Seed

6.3.10 Victoria Seeds Limited

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

Crop Type

Tomato

Cabbage

Onion

Carrot

Okra

Others

 

Geography

Africa

Kenya

Uganda

Nigeria

South Africa

Rest of Africa

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type